AAPL311.44-1.22 (-0.39%) ▼|ABBV260.08+5.38 (+2.11%) ▲|ABT98.10+2.46 (+2.57%) ▲|ACN141.58+4.65 (+3.39%) ▲|ADBE221.92+3.85 (+1.77%) ▲|AMAT536.36-56.43 (-9.52%) ▼|AMD513.22-38.84 (-7.03%) ▼|AMGN372.47+6.03 (+1.65%) ▲|AMT165.90+3.84 (+2.37%) ▲|AMZN248.34+4.18 (+1.71%) ▲|AVGO366.33-7.57 (-2.02%) ▼|AXP354.79-1.24 (-0.35%) ▼|BA232.53-2.01 (-0.86%) ▼|BAC60.49+0.59 (+0.99%) ▲|BKNG185.29+4.26 (+2.35%) ▲|BLK1,012.95+1.74 (+0.17%) ▲|BMY58.20+1.50 (+2.65%) ▲|BNY150.80+0.84 (+0.56%) ▲|BRK-B511.23+4.65 (+0.92%) ▲|C143.48-0.38 (-0.26%) ▼|CAT923.98-45.95 (-4.74%) ▼|CL95.71+2.32 (+2.48%) ▲|CMCSA24.08+0.70 (+2.97%) ▲|COF205.87-0.63 (-0.31%) ▼|COP105.27+1.69 (+1.63%) ▲|COST963.51+13.26 (+1.40%) ▲|CRM168.49+2.84 (+1.71%) ▲|CSCO113.39-0.59 (-0.52%) ▼|CVS103.87+1.79 (+1.75%) ▲|CVX171.58+3.48 (+2.07%) ▲|DE610.16-25.09 (-3.95%) ▼|DHR194.00+0.38 (+0.19%) ▲|DIS98.69+1.28 (+1.32%) ▲|DUK128.98+3.01 (+2.39%) ▲|EMR139.08-2.48 (-1.75%) ▼|FDX310.49+0.56 (+0.18%) ▲|GD376.23-0.66 (-0.17%) ▼|GE370.27-8.41 (-2.22%) ▼|GEV1,047.42-104.62 (-9.08%) ▼|GILD134.30+4.69 (+3.62%) ▲|GM76.68-1.17 (-1.50%) ▼|GOOG369.14+4.24 (+1.16%) ▲|GOOGL371.40+4.94 (+1.35%) ▲|GS1,049.18-6.11 (-0.58%) ▼|HD349.34-1.31 (-0.37%) ▼|HON230.04-1.14 (-0.49%) ▼|IBM301.58+2.06 (+0.69%) ▲|INTC112.11-10.09 (-8.26%) ▼|INTU276.00+3.86 (+1.42%) ▲|ISRG439.18+6.35 (+1.47%) ▲|JNJ267.01+7.68 (+2.96%) ▲|JPM340.32+2.60 (+0.77%) ▲|KO85.17+2.21 (+2.66%) ▲|LIN540.60+0.08 (+0.01%) ▲|LLY1,231.09+31.03 (+2.59%) ▲|LMT541.62+3.62 (+0.67%) ▲|LOW222.75-1.03 (-0.46%) ▼|LRCX323.20-27.00 (-7.71%) ▼|MA539.06+5.96 (+1.12%) ▲|MCD285.51+6.01 (+2.15%) ▲|MDLZ60.98+1.81 (+3.06%) ▲|MDT85.52+2.46 (+2.96%) ▲|META612.10+11.81 (+1.97%) ▲|MMM158.33-0.82 (-0.52%) ▼|MO73.46+1.58 (+2.20%) ▲|MRK128.47+1.69 (+1.33%) ▲|MS222.50+0.40 (+0.18%) ▲|MSFT392.68+5.94 (+1.54%) ▲|MU923.60-61.15 (-6.21%) ▼|NEE88.61+1.17 (+1.34%) ▲|NFLX77.29+1.27 (+1.67%) ▲|NKE43.70+0.36 (+0.83%) ▲|NOW110.40+2.47 (+2.28%) ▲|NVDA192.95-2.60 (-1.33%) ▼|ORCL144.20+0.44 (+0.31%) ▲|PEP148.05+4.76 (+3.32%) ▲|PFE24.15+0.43 (+1.79%) ▲|PG152.60+3.29 (+2.20%) ▲|PLTR133.57+1.03 (+0.78%) ▲|PM187.81+3.05 (+1.65%) ▲|QCOM183.25-3.23 (-1.73%) ▼|RTX202.00+0.63 (+0.31%) ▲|SBUX104.91+2.80 (+2.74%) ▲|SCHW101.00+0.38 (+0.37%) ▲|SO98.16+2.17 (+2.26%) ▲|SPG227.97+2.97 (+1.32%) ▲|T21.22+0.64 (+3.09%) ▲|TMO515.75-1.85 (-0.36%) ▼|TMUS187.07+5.28 (+2.90%) ▲|TSLA415.85-3.92 (-0.93%) ▼|TXN290.56-12.94 (-4.26%) ▼|UBER73.96+1.54 (+2.12%) ▲|UNH423.08+5.09 (+1.22%) ▲|UNP283.89+1.30 (+0.46%) ▲|UPS109.91-0.11 (-0.10%) ▼|USB63.15+0.32 (+0.51%) ▲|V353.70-3.55 (-0.99%) ▼|VZ43.46+1.39 (+3.29%) ▲|WFC88.02+0.57 (+0.65%) ▲|WMT113.19+2.54 (+2.29%) ▲|XOM140.01+3.57 (+2.62%) ▲|AAPL311.44-1.22 (-0.39%) ▼|ABBV260.08+5.38 (+2.11%) ▲|ABT98.10+2.46 (+2.57%) ▲|ACN141.58+4.65 (+3.39%) ▲|ADBE221.92+3.85 (+1.77%) ▲|AMAT536.36-56.43 (-9.52%) ▼|AMD513.22-38.84 (-7.03%) ▼|AMGN372.47+6.03 (+1.65%) ▲|AMT165.90+3.84 (+2.37%) ▲|AMZN248.34+4.18 (+1.71%) ▲|AVGO366.33-7.57 (-2.02%) ▼|AXP354.79-1.24 (-0.35%) ▼|BA232.53-2.01 (-0.86%) ▼|BAC60.49+0.59 (+0.99%) ▲|BKNG185.29+4.26 (+2.35%) ▲|BLK1,012.95+1.74 (+0.17%) ▲|BMY58.20+1.50 (+2.65%) ▲|BNY150.80+0.84 (+0.56%) ▲|BRK-B511.23+4.65 (+0.92%) ▲|C143.48-0.38 (-0.26%) ▼|CAT923.98-45.95 (-4.74%) ▼|CL95.71+2.32 (+2.48%) ▲|CMCSA24.08+0.70 (+2.97%) ▲|COF205.87-0.63 (-0.31%) ▼|COP105.27+1.69 (+1.63%) ▲|COST963.51+13.26 (+1.40%) ▲|CRM168.49+2.84 (+1.71%) ▲|CSCO113.39-0.59 (-0.52%) ▼|CVS103.87+1.79 (+1.75%) ▲|CVX171.58+3.48 (+2.07%) ▲|DE610.16-25.09 (-3.95%) ▼|DHR194.00+0.38 (+0.19%) ▲|DIS98.69+1.28 (+1.32%) ▲|DUK128.98+3.01 (+2.39%) ▲|EMR139.08-2.48 (-1.75%) ▼|FDX310.49+0.56 (+0.18%) ▲|GD376.23-0.66 (-0.17%) ▼|GE370.27-8.41 (-2.22%) ▼|GEV1,047.42-104.62 (-9.08%) ▼|GILD134.30+4.69 (+3.62%) ▲|GM76.68-1.17 (-1.50%) ▼|GOOG369.14+4.24 (+1.16%) ▲|GOOGL371.40+4.94 (+1.35%) ▲|GS1,049.18-6.11 (-0.58%) ▼|HD349.34-1.31 (-0.37%) ▼|HON230.04-1.14 (-0.49%) ▼|IBM301.58+2.06 (+0.69%) ▲|INTC112.11-10.09 (-8.26%) ▼|INTU276.00+3.86 (+1.42%) ▲|ISRG439.18+6.35 (+1.47%) ▲|JNJ267.01+7.68 (+2.96%) ▲|JPM340.32+2.60 (+0.77%) ▲|KO85.17+2.21 (+2.66%) ▲|LIN540.60+0.08 (+0.01%) ▲|LLY1,231.09+31.03 (+2.59%) ▲|LMT541.62+3.62 (+0.67%) ▲|LOW222.75-1.03 (-0.46%) ▼|LRCX323.20-27.00 (-7.71%) ▼|MA539.06+5.96 (+1.12%) ▲|MCD285.51+6.01 (+2.15%) ▲|MDLZ60.98+1.81 (+3.06%) ▲|MDT85.52+2.46 (+2.96%) ▲|META612.10+11.81 (+1.97%) ▲|MMM158.33-0.82 (-0.52%) ▼|MO73.46+1.58 (+2.20%) ▲|MRK128.47+1.69 (+1.33%) ▲|MS222.50+0.40 (+0.18%) ▲|MSFT392.68+5.94 (+1.54%) ▲|MU923.60-61.15 (-6.21%) ▼|NEE88.61+1.17 (+1.34%) ▲|NFLX77.29+1.27 (+1.67%) ▲|NKE43.70+0.36 (+0.83%) ▲|NOW110.40+2.47 (+2.28%) ▲|NVDA192.95-2.60 (-1.33%) ▼|ORCL144.20+0.44 (+0.31%) ▲|PEP148.05+4.76 (+3.32%) ▲|PFE24.15+0.43 (+1.79%) ▲|PG152.60+3.29 (+2.20%) ▲|PLTR133.57+1.03 (+0.78%) ▲|PM187.81+3.05 (+1.65%) ▲|QCOM183.25-3.23 (-1.73%) ▼|RTX202.00+0.63 (+0.31%) ▲|SBUX104.91+2.80 (+2.74%) ▲|SCHW101.00+0.38 (+0.37%) ▲|SO98.16+2.17 (+2.26%) ▲|SPG227.97+2.97 (+1.32%) ▲|T21.22+0.64 (+3.09%) ▲|TMO515.75-1.85 (-0.36%) ▼|TMUS187.07+5.28 (+2.90%) ▲|TSLA415.85-3.92 (-0.93%) ▼|TXN290.56-12.94 (-4.26%) ▼|UBER73.96+1.54 (+2.12%) ▲|UNH423.08+5.09 (+1.22%) ▲|UNP283.89+1.30 (+0.46%) ▲|UPS109.91-0.11 (-0.10%) ▼|USB63.15+0.32 (+0.51%) ▲|V353.70-3.55 (-0.99%) ▼|VZ43.46+1.39 (+3.29%) ▲|WFC88.02+0.57 (+0.65%) ▲|WMT113.19+2.54 (+2.29%) ▲|XOM140.01+3.57 (+2.62%) ▲|
17.9 C
New York
Tuesday, July 7, 2026

Tag: program

newssourceFORcompanyinformationcontent1releasesmarket

Stanbridge University’s Vocational Nursing Program Ranked #1 in California by Nursingprocess.org

Stanbridge’s VN program ranked #1 in CA by Nursingprocess.org, recognizing top NCLEX-PN pass rates, academic quality, and student success.

Fabrix.ai’s Enterprise-grade Agentic AI Platform Generates Strong Interest at Cisco Live’25

Fabrix.ai Successfully Demonstrated AI-Powered Network Operations and Autonomous Agents; Cisco Validated Zone Showcase Draws customer attention PLEASANTON, Calif., June 26, 2025 /PRNewswire/ -- Fabrix.ai (...

Everest Medicines to Host Virtual Nephrology-Focused KOL Event on June 30, 2025

SHANGHAI, June 26, 2025 (GLOBE NEWSWIRE) -- Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it will host a virtual nephrology-focused key opinion leader (KOL) event on Monday, June 30, 2025 at 8:00 AM ET. For English speakers, please click here to register. For individuals preferring instant Chinese translation, please click here.

BGX Outlines Strategy for Expansion

Black Gold Unveils Scalable Blueprint for Illinois Basin Development 
Black Gold Unveils Scalable Blueprint for Illinois Basin Development

Hexaware Achieves Guidewire Migration Acceleration Specialization

ISELIN, N.J., June 26, 2025 /PRNewswire/ -- Hexaware Technologies (NSE: HEXT), today announced that it has been awarded the Guidewire Migration Acceleration specialization as...

FEMA Support Insufficient—Insurance Coverage Remains Essential for Risk Management

The imminent restructuring of the Federal Emergency Management Agency (FEMA) under the Trump administration could significantly alter disaster recovery dynamics for homeowners. This shift...

Hydrite® Announces Strategic Advancement in Food Ingredient Program

BROOKFIELD, Wis., June 26, 2025 /PRNewswire/ -- Hydrite®, an integrated manufacturer and supplier of ingredients, processing aids, and related services, is pleased to announce...

Ascent Solar Technologies Enters Collaborative Agreement Notice with NASA to Advance Development of Thin-Film PV Power Beaming Capabilities

THORNTON, Colo., June 26, 2025 (GLOBE NEWSWIRE) -- Ascent Solar Technologies (Nasdaq: ASTI) (“Ascent” or the “Company”), the leading U.S. innovator in the design and manufacture of featherweight, flexible, and durable CIGS thin-film photovoltaic (PV) solutions, announced today that the company is commencing work on a Collaborative Agreement Notice (CAN) with NASA Marshall Space Flight Center (MSFC) and support from NASA Glenn Research Center (GRC) to efficiently advance capabilities for receiving beamed power using CIGS PV modules.

Cascadia Provides Exploration Update, Announces AGM Results and Grant of Options

VANCOUVER, BC, June 26, 2025 /CNW/ - Cascadia Minerals Ltd. ("Cascadia") (TSXV: CAM) (OTCQB: CAMNF) is pleased to provide an update on phase one...

NORTHCLIFF ANNOUNCES PROGRESS REPORT ON PROGRAM TO ADVANCE DEVELOPMENT OF THE SISSON CRITICAL MINERALS PROJECT

VANCOUVER, BC, June 26, 2025 /CNW/ - Northcliff Resources Ltd. ("Northcliff" or the "Company") (TSX: NCF) is pleased to announce that it has engaged...

White Castle Celebrates 100 Years in St. Louis with Local Love, Exclusive Deals and a One-of-a-Kind Combo

"The Lou" combo spotlights regional tastes that made St. Louis a Craver capital, plus every 100th customer eats free between July 13-19 COLUMBUS, Ohio, June...

Scinai Highlights Award-Winning Science Behind PC111 as Key Pincell Researcher Receives “Oscar of Italian Dermatology”

Dr. Roberta Lotti honoured for a pioneering work on PC111, reinforcing Scinai's strategic option agreement to acquire the Italian biotech company Pincell srl. JERUSALEM, June 26,...

Palomar and Neptune Partner to Accelerate Growth in U.S. Flood Insurance Market

~ Palomar to Appoint Neptune as Exclusive Managing General Agent for Flood Insurance ~

BridgeBio to Host Limb-girdle Muscular Dystrophy Type 2I/R9 Investor Webinar on Friday, July 11th at 8:00 am ET

PALO ALTO, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced the Company will host an investor webinar on Friday, July 11, 2025 at 8:00 am ET with Matthew Wicklund, M.D., FAAN, Professor of Neurology and Vice Chair for Research, Department of Neurology at the University of Texas (UT) Health Science Center San Antonio.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsProgram

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers